Literature DB >> 26408182

Detection of DNA repair protein in colorectal cancer of patients up to 50 years old can increase the identification of Lynch syndrome?

Demétrius Eduardo Germini1, Ana Maria Amaral Antônio Mader2, Luiz Guilherme Lisboa Gomes3, Thérèse Rachel Teodoro4, Maria Isete Fares Franco5, Jaques Waisberg3.   

Abstract

The aim of this study was to compare the results of protein level of the DNA mismatch repair genes with the clinical diagnosis of Lynch syndrome according to the Amsterdam II criteria in patients 50 years and younger who underwent surgery for colorectal cancer. The subjects of analysis were 48 patients 50 years old and younger. Immunohistochemistry assays were performed to detect proteins from the DNA mismatch repair genes. Clinicopathological data and Amsterdam II criteria for the diagnosis of hereditary nonpolyposis colorectal cancer were obtained by analyzing medical records. Two (4 %) patients satisfied the Amsterdam II criteria for Lynch syndrome, and both presented levels of all of the studied mismatch repair proteins. A total of 13 (27 %) patients exhibited the absence of protein levels of the studied mismatch repair genes. None of these patients were considered suspicious for Lynch syndrome according to the Amsterdam II criteria. Screening for the level of proteins of the mismatch repair system in all colorectal cancer patients 50 years and younger can increase the identification of patients with suspicion of Lynch syndrome.

Entities:  

Keywords:  Colorectal neoplasms; DNA mismatch repair; Hereditary nonpolyposis; Immunohistochemistry; Lynch syndrome; MutS DNA mismatch-binding protein

Mesh:

Substances:

Year:  2015        PMID: 26408182     DOI: 10.1007/s13277-015-4108-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  45 in total

1.  A role for MLH3 in hereditary nonpolyposis colorectal cancer.

Authors:  Y Wu; M J Berends; R H Sijmons; R G Mensink; E Verlind; K A Kooi; T van der Sluis; C Kempinga; A G van dDer Zee; H Hollema; C H Buys; J H Kleibeuker; R M Hofstra
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

2.  MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer.

Authors:  Bente A Talseth-Palmer; Mary McPhillips; Claire Groombridge; Allan Spigelman; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2010-05-21       Impact factor: 2.857

3.  MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer.

Authors:  J Huang; S A Kuismanen; T Liu; R B Chadwick; C K Johnson; M W Stevens; S K Richards; J E Meek; X Gao; F A Wright; J P Mecklin; H J Järvinen; H Grönberg; M L Bisgaard; A Lindblom; P Peltomäki
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

4.  Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer.

Authors:  Paul J Limburg; William S Harmsen; Helen H Chen; Steven Gallinger; Robert W Haile; John A Baron; Graham Casey; Michael O Woods; Stephen N Thibodeau; Noralane M Lindor
Journal:  Clin Gastroenterol Hepatol       Date:  2010-11-05       Impact factor: 11.382

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  Surgery for colonic cancer in HNPCC: total vs segmental colectomy.

Authors:  D A Stupart; P A Goldberg; R J Baigrie; U Algar; R Ramesar
Journal:  Colorectal Dis       Date:  2011-12       Impact factor: 3.788

7.  Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer.

Authors:  Jianhui Guo; Li Zheng; Wenyong Liu; Xianshu Wang; Zemin Wang; Zehua Wang; Amy J French; Dongchon Kang; Lin Chen; Stephen N Thibodeau; Wanguo Liu
Journal:  Cancer Res       Date:  2011-04-05       Impact factor: 12.701

8.  Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic.

Authors:  Patrícia Koehler-Santos; Patricia Izetti; Jamile Abud; Carlos Eduardo Pitroski; Silvia Liliana Cossio; Suzi Alves Camey; Cláudio Tarta; Daniel C Damin; Paulo Carvalho Contu; Mario Antonello Rosito; Patricia Ashton-Prolla; João Carlos Prolla
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

9.  Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry.

Authors:  Jinru Shia
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

10.  Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

Authors:  Johanne Geary; Peter Sasieni; Richard Houlston; Louise Izatt; Ros Eeles; Stewart J Payne; Samantha Fisher; Shirley V Hodgson
Journal:  Fam Cancer       Date:  2007-10-16       Impact factor: 2.375

View more
  3 in total

1.  Locked nucleic acid inhibits miR-92a-3p in human colorectal cancer, induces apoptosis and inhibits cell proliferation.

Authors:  S Ahmadi; M Sharifi; R Salehi
Journal:  Cancer Gene Ther       Date:  2016-05-20       Impact factor: 5.987

2.  A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.

Authors:  Benedito Mauro Rossi; Edenir Inêz Palmero; Francisco López-Kostner; Carlos Sarroca; Carlos Alberto Vaccaro; Florencia Spirandelli; Patricia Ashton-Prolla; Yenni Rodriguez; Henrique de Campos Reis Galvão; Rui Manuel Reis; André Escremim de Paula; Luis Gustavo Capochin Romagnolo; Karin Alvarez; Adriana Della Valle; Florencia Neffa; Pablo German Kalfayan; Enrique Spirandelli; Sergio Chialina; Melva Gutiérrez Angulo; Maria Del Carmen Castro-Mujica; Julio Sanchez de Monte; Richard Quispe; Sabrina Daniela da Silva; Norma Teresa Rossi; Claudia Barletta-Carrillo; Susana Revollo; Ximena Taborga; L Lena Morillas; Hélène Tubeuf; Erika Maria Monteiro-Santos; Tamara Alejandra Piñero; Constantino Dominguez-Barrera; Patrik Wernhoff; Alexandra Martins; Eivind Hovig; Pål Møller; Mev Dominguez-Valentin
Journal:  BMC Cancer       Date:  2017-09-05       Impact factor: 4.430

3.  Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study.

Authors:  Jiao Yang; Shuting Li; Meng Lv; Yinying Wu; Zheling Chen; Yanwei Shen; Biyuan Wang; Ling Chen; Min Yi; Jin Yang
Journal:  Onco Targets Ther       Date:  2017-03-13       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.